Cargando…

Mineralocorticoid receptor deficiency improves the therapeutic effects of mesenchymal stem cells for myocardial infarction via enhanced cell survival

The poor survival of stem cells seriously limits their therapeutic efficacy for myocardial infarction (MI). Mineralocorticoid receptor (MR) activation plays an important role in the pathogenesis of multiple cardiovascular diseases. Here, we examined whether MR silencing in bone marrow derived mesenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xinxing, Shen, Yunli, Chen, Jing, Huang, Zheyong, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349200/ https://www.ncbi.nlm.nih.gov/pubmed/30549184 http://dx.doi.org/10.1111/jcmm.14026

Ejemplares similares

Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction
por: Huang, Bingqing, et al.
Publicado: (2014)

Magnetic resonance hypointensive signal primarily originates from extracellular iron particles in the long-term tracking of mesenchymal stem cells transplanted in the infarcted myocardium
por: Huang, Zheyong, et al.
Publicado: (2015)

A novel method to delivery stem cells to the injured heart: spatially focused magnetic targeting strategy
por: Huang, Zheyong, et al.
Publicado: (2012)

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction
por: Huang, Zheyong, et al.
Publicado: (2013)

High Density Lipoprotein Protects Mesenchymal Stem Cells from Oxidative Stress-Induced Apoptosis via Activation of the PI3K/Akt Pathway and Suppression of Reactive Oxygen Species
por: Xu, Jianfeng, et al.
Publicado: (2012)

Histamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosis
por: Deng, Long, et al.
Publicado: (2015)

Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles
por: Shen, Yunli, et al.
Publicado: (2015)

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017)

Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
por: Ozaki Tan, Sho Joseph, et al.
Publicado: (2020)

Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome
por: Shao, Lianbo, et al.
Publicado: (2022)

Identification of Myocardial Telocytes and Bone Marrow Mesenchymal Stem Cells in Mice
por: Zhong, Xin, et al.
Publicado: (2018)

Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing
por: Fraccarollo, Daniela, et al.
Publicado: (2019)

Therapeutic Use of Stem Cells for Myocardial Infarction
por: Madigan, Mariah, et al.
Publicado: (2018)

A New Coronary Retroinfusion Technique in theRat Infarct Model: Transjugular Cardiac Vein Catheterization
por: Huang, Zheyong, et al.
Publicado: (2013)

miRNA-130b is required for the ERK/FOXM1 pathway activation-mediated protective effects of isosorbide dinitrate against mesenchymal stem cell senescence induced by high glucose
por: XU, JIANFENG, et al.
Publicado: (2015)

Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells
por: Sullivan, Kelly Elizabeth, et al.
Publicado: (2014)

A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction
por: Miao, Chi, et al.
Publicado: (2017)

Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells in Myocardial Infarction by Promoting Angiogenesis
por: Chen, Jingrui, et al.
Publicado: (2018)

In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction
por: Pei, Zhijun, et al.
Publicado: (2017)

Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
por: Hao, Tian, et al.
Publicado: (2023)

Effects of salvianolate on myocardial perfusion after primary percutaneous catheter intervention in patients with ST-segment elevation myocardial infarction: a multicenter, randomized, double-blind, placebo-controlled study
por: Shen, Li, et al.
Publicado: (2020)

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
por: Carvalho, Juliana L, et al.
Publicado: (2013)

Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015)

Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction
por: Li, HuiYa, et al.
Publicado: (2021)

miR‐15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction
por: Tu, Yingfeng, et al.
Publicado: (2019)

Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction
por: Wen, Zhuzhi, et al.
Publicado: (2011)

Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
por: Chen, Zhi, et al.
Publicado: (2018)

Chitosan hydrogel improves mesenchymal stem cell transplant survival and cardiac function following myocardial infarction in rats
por: Xu, Bin, et al.
Publicado: (2017)

Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival
por: Chen, Guona, et al.
Publicado: (2022)

Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142
por: Yang, Liu-Xue, et al.
Publicado: (2017)

FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020)

Therapeutic Potential of Exosomes Derived From circRNA_0002113 Lacking Mesenchymal Stem Cells in Myocardial Infarction
por: Tian, Tiantian, et al.
Publicado: (2022)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
por: Löfman, Ida, et al.
Publicado: (2018)

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure
Publicado: (2019)

Impact of mineralocorticoid receptor gene NRC2 on the prediction of arrhythmia after acute myocardial infarction
por: Daniulaityte, K, et al.
Publicado: (2023)

Fibrin‐targeting delivery: a novel platform for cardiac regenerative medicine
por: Huang, Zheyong, et al.
Publicado: (2016)

Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction
por: Zhao, Shu-Li, et al.
Publicado: (2014)

Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
por: Tao, Yue, et al.
Publicado: (2021)

Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction
por: Tao, Yue, et al.
Publicado: (2022)

Myocardial infarction and stem cells
por: Krishna, K. Ananda, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3f58fpu4oilb8m1go1njptkvsp